Literature DB >> 12707007

Historical review: Opioid receptors.

Solomon H Snyder1, Gavril W Pasternak.   

Abstract

A historical review of the early phases of molecular investigations of opioid receptors is presented. The 'modern' era of molecular studies of neurotransmitter and drug receptor research commenced in the 1970s with the identification of receptors using ligand binding techniques. These findings had several ramifications. Reversible ligand binding to opioid receptors using simple, sensitive and specific techniques provided a paradigm for the study of receptors for the principal neurotransmitters in the brain. The relatively high-throughput binding techniques employed facilitated drug development in the pharmaceutical industry. Differentiation of agonist and antagonist receptor interactions by Na(+) ions and other substances helped elucidate how ligand recognition at receptors is translated into second messenger alterations. Localizations of opioid receptors clarified many of the pharmacological actions of opiate drugs. Differential binding interactions of various drugs led to the identification of opioid receptor subtypes. Receptor influences in binding paradigms and smooth muscle pharmacology permitted the identification and isolation of endogenous opioid peptides.

Mesh:

Substances:

Year:  2003        PMID: 12707007     DOI: 10.1016/S0165-6147(03)00066-X

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  41 in total

Review 1.  Post-transcriptional regulation of opioid receptors in the nervous system.

Authors:  Li-Na Wei; Ping-Yee Law; Horace H Loh
Journal:  Front Biosci       Date:  2004-05-01

Review 2.  Kappa-opioid ligands in the study and treatment of mood disorders.

Authors:  William A Carlezon; Cécile Béguin; Allison T Knoll; Bruce M Cohen
Journal:  Pharmacol Ther       Date:  2009-06-02       Impact factor: 12.310

Review 3.  Historical evolution of the neurotransmission concept.

Authors:  Francisco López-Muñoz; Cecilio Alamo
Journal:  J Neural Transm (Vienna)       Date:  2009-04-07       Impact factor: 3.575

Review 4.  Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptides.

Authors:  Lydiane Funkelstein; Margery Beinfeld; Ardalan Minokadeh; James Zadina; Vivian Hook
Journal:  Neuropeptides       Date:  2010-11-02       Impact factor: 3.286

Review 5.  Pharmacogenetic approaches to the treatment of alcohol addiction.

Authors:  Markus Heilig; David Goldman; Wade Berrettini; Charles P O'Brien
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

6.  Determination of the minimal functional ligand-binding domain of the GABAB1b receptor.

Authors:  Daniela Deriu; Martin Gassmann; Susan Firbank; Dorothee Ristig; Christina Lampert; Johannes Mosbacher; Wolfgang Froestl; Klemens Kaupmann; Bernhard Bettler; Markus G Grütter
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

7.  The role of a sodium ion binding site in the allosteric modulation of the A(2A) adenosine G protein-coupled receptor.

Authors:  Hugo Gutiérrez-de-Terán; Arnault Massink; David Rodríguez; Wei Liu; Gye Won Han; Jeremiah S Joseph; Ilia Katritch; Laura H Heitman; Lizi Xia; Adriaan P Ijzerman; Vadim Cherezov; Vsevolod Katritch; Raymond C Stevens
Journal:  Structure       Date:  2013-11-07       Impact factor: 5.006

8.  Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand.

Authors:  Yan Zhang; Amanda Braithwaite; Yunyun Yuan; John M Streicher; Edward J Bilsky
Journal:  Eur J Pharmacol       Date:  2014-05-08       Impact factor: 4.432

9.  Placebo and Active Treatment Additivity in Placebo Analgesia: Research to Date and Future Directions.

Authors:  Matthew J Coleshill; Louise Sharpe; Luana Colloca; Robert Zachariae; Ben Colagiuri
Journal:  Int Rev Neurobiol       Date:  2018-08-06       Impact factor: 3.230

Review 10.  Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications.

Authors:  N T Burford; J R Traynor; A Alt
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.